Study Reports Daily Aspirin is Not a Magic Bullet
Story Highlights For many years, doctors have recommended a daily low-dose aspirin to reduce the risk for heart attacks, strokes, cancer and other health problems. A new study alleges that common practice has no benefit for healthy older adults, instead reporting an increased risk of mortality from all causes for those taking aspirin compared to a […]
The Hidden Dangers of Tattoos
Along with a growing movement of consumers turning their backs on GMO and processed foods, toxic pesticides, mandatory vaccinations, mercury dental amalgams and fluoride treated drinking water, another and curiously contradictory trend is also sweeping the country…
Americans Are on More Drugs Than Ever
If you’re a U.S. adult and don’t regularly take a prescription drug, you’re now in the minority, according to a survey of nearly 2,000 U.S. adults by Consumer Reports.1 The revealing sample found that more than half of U.S. adults regularly take prescription medications, and the average adult takes four.
Brenda Fitzgerald Eyed for CDC Director Post
The Trump administration is reportedly expected to appoint Brenda Fitzgerald, MD as the new director of the Centers for Disease Control and Prevention (CDC). A decision on Dr. Fitzgerald has not been finalized. According to a recent report by the Atlanta Journal-Constitution…
Malaria Burden Worldwide Has Dropped Without Vaccines
It is a common position taken by vaccination proponents that vaccines deserve all the credit for the worldwide decrease in incidence and mortality from communicable diseases since the early 1900s. Last month, vaccines were credited with saving nearly a half million lives since 1963, in the U.S. alone. This popular stance glosses over such contributing factors as management of sewage…
EpiPen’s Notorious Marketing Model
It’s a great business model: Start (or find) a life-threatening trend, develop (or acquire) a product absolutely necessary to counteract that trend, then gradually raise the cost until you find the highest price the market will bear. No wonder Mylan, the company that owns the EpiPen, is being compared—and unfavorably yet—to Turing Pharmaceuticals and its former chief executive Marti Shkreli, the man…
